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Stress technetiumPotential Implications for Hospital Personnel and the PublicTo the Editor: Myocardial perfusion imaging (MPI) is unique in
that patients administered radioactive pharmaceuticals continue to
emit radiation following study completion, with potential radia-
tion exposure to others. Despite the wealth of data regarding
increasing radiation exposure in patients undergoing medical
testing, there are few data regarding radiation exposure in others
after MPI. We therefore measured the radiation emitted by
patients after undergoing clinical MPI and found that radiation
exposure in people in close proximity to the patient in the ﬁrst few
hours after radioisotope injection may be important, particularly in
individuals with repeated exposures and/or in vulnerable pop-
ulations. As expected, there was a large reduction in radiation
exposure with small increases in distance, highlighting the
importance of the effect of distance on radiation exposure, a key
radiation safety principle.
Our methods are outlined in the Online Appendix. We pro-
spectively evaluated data from 56 subjects (mean age: 68 
12 years; 37 (66%) men; mean weight: 83  15 kg) referred
for single-day technetium (Tc)-99m sestamibi MPI. The mean
Tc-99m–administered activity values at rest and during stress were
381  26 MBq and 1,135  80 MBq, respectively. Radiation
measurements were obtained in 46 subjects using an ionization
chamber (IC) and Geiger-Muller (GM) survey meter at the center
of the chest wall; at the right elbow; and at 0.3, 1, and 2 m fromError Radiation Exposure Rates After
(Tc)-99m Radioisotope Injectionthe right chest wall immediately after the completion of the
MPI study. Additional GM measurements were obtained from
inpatients at the time of arrival to the hospital ﬂoor (1.51  0.56 h
following stress injection) and at 1, 2, and 4 h after arrival.
Radiation dose rate data are summarized in Figure 1. Film badge
dosimetry was obtained in 10 additional subjects. For an exposure
of 27.6  8.1 min beginning at 1.5 h after radionuclide admin-
istration, the anterior chest wall dose equivalent was 0.37 
0.13 mSv and the right chest wall dose equivalent was 0.58 
0.26 mSv.
We estimated cardiac sonographer–patient contact time and
transport-staff duration with patients at our institution as 24  8
min and 10  6 min, respectively, based on a consecutive review of
64 echocardiographic studies and 44 transportation logs. A right-
handed sonographer positioned at the right elbow to chest wall
would have a potential radiation dose equivalent of 0.10 to 0.16
mSv at 1.5 h after stress injection. For a left-hand scanning
sonographer at 0.3 m, the dose equivalent would be 0.04 mSv. For
a transport worker, a 10-min exposure at 0.3 m would impart
a dose equivalent of 0.02 mSv. Film badge dosimetry demonstrated
an even greater estimate of radiation exposure.
Others have measured radiation exposure in nuclear medicine
staff (1–3). These studies have yielded small radiation dose rates,
which were greatest with Tc-99m MPI studies and with expo-
sures requiring prolonged close contact. Although dosimeters
worn at different locations have been used (2), the measurements
may not reﬂect exposure to sonographers, who are in immediate
contact with patients for a prolonged period. Badge position may
affect the measurement due to the signiﬁcant change in exposure
rates over small distances. Our patient badges were placed in the
location of cardiac sonographers’ contact with patients during
scanning.
Current practice behavior may increase occupational radiation
exposure, with scheduling of multiple same-day tests to expedite
hospital discharge or to consolidate outpatient testing for patients’
convenience. At our 660-bed medical center, an inpatient is
brought from MPI testing to the echocardiography laboratory
approximately once daily. At many institutions, transport
personnel may be assigned to an area for prolonged periods. Non–
nuclear medicine personnel do not receive radiation safety
training and may be unaware of the potential risks of radiation
exposure and the simple methods of protecting themselves from
radiation emitted by patients. Without guidelines in the man-
agement and scheduling of post-MPI patients, a sonographer
with repeated exposures may approach or exceed the 20-mSv/year
(100 mSv/5 yrs) guideline recommendation (4) or the goal of
10% of this limit used by many centers. Paradigms to facilitate
rotation of exposed staff and scheduling of echocardiographic
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352examinations before or at least 4 hours after MPI are needed.
Other services in which medical staff have prolonged close
patient contact should occur outside of this window. If resched-
uling cannot occur, the use of lead aprons by staff working closely
with patients should be considered during the ﬁrst 4 h following
MPI.
Experts have suggested that it is difﬁcult to generate deﬁnitive
conclusions about the health risks attributable to radiation
doses<50 mSv in 1 year or<100 mSv over a lifetime (5). Although
it is unlikely that repeated exposure to post-MPI patients will exceed
these limits in adults, our data suggest that close and repeated
contact should be avoided in populations that are more radiosen-
sitive, such as pregnant women and children.
An estimation of the total effective dose equivalent was not the
subject of our study and would be exceedingly challenging given the
variability in the time of exposure, distance, and body position. Our
measures of radiation exposure are routinely performed by radiation
safety departments.
MPI is an important tool in the evaluation of patients for coro-
nary artery disease, providing valuable diagnostic and prognostic
information. Current recommendations for the appropriate use of
MPI generally limit its use to those patients with at least interme-
diate risk, inability to exercise, an abnormal baseline electrocardio-
gram, or other situations in which the risk–beneﬁt ratio is favorable.
Our data conﬁrm that radiation exposure to hospital personnel and
the public can be minimized by maintaining adequate distance from
the patient. Instituting appropriate changes in scheduling, the use of
lead shielding, and patient education can further aid in reducing
radiation exposure in others.Connie W. Tsao, MD
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For more details on the methods, as well as supplemental ﬁgures, please
see online version of this article.Letters to the EditorMultidetector Computed
Tomography Stress-Rest
Perfusion Imaging for
Detection of Coronary
Artery Disease
Dr. Bettencourt and colleagues compare the diagnostic perfor-
mance of multidetector computed tomography (MDCT) stress-
rest perfusion imaging (using signiﬁcantly lower dose radiation)
with cardiac magnetic resonance myocardial perfusion imaging
(CMR-Perf) for detection of functionally signiﬁcant coronary
artery disease with fractional ﬂow reserve (FFR) as reference
standard (1).
It would be interesting to know the following. First, did the
authors make an attempt to compare performance of computed
tomography perfusion (CTP) and CMR-Perf among patients
with multivessel disease or those with >70% stenosis? Second, did
the authors make an attempt to investigate the lesions labeled
“false positive” on CTP, which could be incorrectly labeled as
“false positive” in setting of nonobstructive coronaries (due to
thrombus recannalization or post-percutaneous coronary interven-
tion)? The authors measured FFR in vessels with >40% stenosis;
however, abnormal FFR can be found in vessels with lesser degree
of stenosis (2). This is more important in setting of microvascular
disease, which has worse prognosis. CTP could be particularly
helpful in such scenario due to its high resolution and ability to
evaluate parameters of endothelial function and microvascular
circulation (3).
Though use of 17-segment model to compare CTP and CMR-
Perf is itself not perfect, due to overlap of segments between various
coronary territories, the current report is a welcome step in the
ongoing search for “1-stop” cardiac imaging modality.
However, an important practical limitation of CTP at this time
is need for designated software for image analyses and substantial
expertise to interpret images and make accurate diagnoses. Further,
as patient population in current study was very selective, it would be
interesting to see in future studies how MDCT-integrated protocol
performs in “real world.”*Abhishek Sharma, MD
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